Endocrine System Diseases  >>  AZD4017  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AZD4017 / AstraZeneca
MAD, NCT00841048: Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD4017 After Repeated Ascending Oral Doses

Completed
1
107
Europe
AZD4017, Placebo
AstraZeneca
Diabetes Mellitus Type 2
 
05/09

Download Options